Performance figures of the catheter laboratories (CL) operated in Germany have been published recently for the years 2006 [6] and 2007 [7] . The 25th anniversary report will follow shortly. Since 1985, these annual reports are, the only valid sources of information reporting character and frequency of diagnostic and therapeutic cardiac procedures performed in Europe's largest medical community [9, 12] . Governmental registries that came up only in the last 10 years (''BQS'' for inpatient procedures and ''Quik'' for outpatient procedures), provided incomplete data sets in their first years as no complete documentations were acquired and the number of requested items was considerably low [1, 18, 32] .
Participation in this registry is voluntary, but with a nonresponder rate as low as 1.5% in 2007 well accepted. Data collection and processing is strictly anonymous resulting in some shortcomings: (a) although anonymously, reported data may be incorrect which cannot be re-checked; (b) the registry does not provide quality insurance data; and (c) to generate a more or less complete data set, some institutions are contacted up to ten times to finally have their data available. This results in a significant publication delay.
To prevent non-uniform countings, every centre is annually provided with an explanation on how data should be reported, e.g. procedures with diagnostic angiogram and subsequent PCI in one session have to be counted as one angiogram and one PCI.
In , respectively, keeping Germany in the leading European position regarding both, the frequency of diagnostic (1,010/100,000 population) and therapeutic coronary procedures (363/100,000) per population [7] . In 2007, the average volume per CL has been as low as 1,119 coronary angiographies and 403 coronary interventions. Compared to the 2006 numbers, this is a decrease per CL of 9.2 and 9.4%, respectively.
These figures are remarkable for several reasons:
1. Despite the fact that morbidity and mortality of ischaemic heart disease does not differ much among medical countries in Central Europe, the rates of both diagnostic and therapeutic coronary procedures vary widely [9, 19] . As recent randomized trials seem to indicate that coronary interventions in patients with chronic stable angina do not result in an improvement of outcomes [3, 4, 29] , it is not unexpected that the high rates of coronary procedures performed in Germany do not translate into corresponding reduction in coronary events. In Europe there were 951 diagnostic studies and 284 coronary interventions per cathlab (2000) [2] . The US data for 2004 indicated a mean annual PCI volume of 666 ± 550 per cathlab [22] . There is a massive discrepancy between the overall number of coronary procedures performed in Germany and the still relatively low percentage of patients with ST elevation myocardial infarction (STEMI) that undergo acute mechanical revascularization. Consequently, mortality rates STEMI remain high in Germany (70.3/100,000 population), while figures for Austria (61.3/100,000 population) and Switzerland (36.0/ 100,000 population) compare favourably. One reason is deregulation allowing every institution to operate a CL despite an already high supply density. One frequent argument is that emergency cases must be managed within short transportation times, although it has been shown that transportation time in nearly all parts of Germany with its dense population is of neglectable importance [28] . The wide spread of CL in Germany not only result in small units with a low overall intervention rate but also in time delays due to ineffective standby services. Although the number of coronary interventions for acute coronary syndromes (ACS) has constantly increased from 61,251 in 2005, 62,863 in 2006 (?2.6%), to 69,738 in 2007 (?11.0%), they are still insufficiently low [16, 19, 20] .
In 2002 only 44% of STEMI patients underwent an acute revascularization procedure. Thirty-seven percent received neither mechanical revascularization nor thrombolysis [16, 20] . In the Euro Heart Survey ACS-III, the percentage of STEMI patients who underwent reperfusion increased from 77.2% (2006) to 81.3% (2008) mainly due to the increase in acute percutaneous coronary interventions [25] . Figures in type 2 diabetics remain even lower despite the fact that the prognostic benefit for this patient group is especially high [16, 20] .
Taking the positive long-term results of PCI with adjuvant drug-eluting stent (DES) implantation as compared to subgroups with no stents or bare metal stent implantations into account [11, 15, 21, 22, 26] , the current use of DES is considered rather restrictive [27, 28] . Despite the low percentage of PCI patients receiving DES in Germany (24.0% in 2005 and 29.4% in 2006) the percentage further decreased in 2007 (27.5%). In general, this may reflect the economic situation of an average German hospital and the decrease in 2007 in particular may reflect the concerns on the long-term outcome after DES due to acute stent thrombosis arising during the 2007 ESC congress in Barcelona [8] .
Nonetheless, the rate of 14% DES per 100 coronary procedures in Germany in 2005 has been lower at any time than in other European countries, e.g. Austria (66%), Spain (61%) and Portugal (49%) [9, 10, 23] .
The discussion of all these circumstances might lead to the opinion that both, diagnostic and interventional procedures in Germany are done more often than necessary. However, the incidence of coronary artery disease is still rising and increasing number of cathlabs in Germany might dignify this circumstance.
